First and only BTK inhibitor to be granted provincial formulary approval TORONTO, ON — /CNW/ — BeiGene Canada, the affiliate of BeiGene, Ltd. (NASDAQ: BGNE) (HKEX: 06160) (SSE: 688235), a global… Read More
PharmAla Biotech is the only company in the world with the ability to ship GMP MDMA and Psilocybin today VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the… Read More
VANCOUVER, BC — Platform Life Sciences, a high impact Clinical Research Organization, with the mission to modernize clinical trials on a global scale, has signed a key agreement with GreenLight… Read More
TORONTO, ON — LifeLabs is pleased to share the launch of SignateraTM, a highly sensitive, personalized molecular residual disease assay (MRD) test developed by Natera for treatment monitoring and molecular residual disease… Read More
Clinical trial will be the first to test whole Psilocybe mushrooms for safety and efficacy in a clinical setting; study is expected to provide important data to support increased access to… Read More
